Gälman C - Search Results

1

Importance of proprotein convertase subtilisin/kexin type 9 in the hormonal and dietary regulation of rat liver low-density lipoprotein receptors.

Persson L, Gälman C, Angelin B, Rudling M. Persson L, et al. Among authors: galman c. Endocrinology. 2009 Mar;150(3):1140-6. doi: 10.1210/en.2008-1281. Epub 2008 Nov 13. Endocrinology. 2009. PMID: 19008317

2

Prolonged stimulation of the adrenals by corticotropin suppresses hepatic low-density lipoprotein and high-density lipoprotein receptors and increases plasma cholesterol.

Gälman C, Angelin B, Rudling M. Gälman C, et al. Endocrinology. 2002 May;143(5):1809-16. doi: 10.1210/endo.143.5.8816. Endocrinology. 2002. PMID: 11956163

3

Age-induced hypercholesterolemia in the rat relates to reduced elimination but not increased intestinal absorption of cholesterol.

Gälman C, Matasconi M, Persson L, Parini P, Angelin B, Rudling M. Gälman C, et al. Am J Physiol Endocrinol Metab. 2007 Sep;293(3):E737-42. doi: 10.1152/ajpendo.00166.2007. Epub 2007 Jun 19. Am J Physiol Endocrinol Metab. 2007. PMID: 17578886 Free article.

4

Circulating proprotein convertase subtilisin kexin type 9 has a diurnal rhythm synchronous with cholesterol synthesis and is reduced by fasting in humans.

Persson L, Cao G, Ståhle L, Sjöberg BG, Troutt JS, Konrad RJ, Gälman C, Wallén H, Eriksson M, Hafström I, Lind S, Dahlin M, Amark P, Angelin B, Rudling M. Persson L, et al. Among authors: galman c. Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2666-72. doi: 10.1161/ATVBAHA.110.214130. Epub 2010 Sep 30. Arterioscler Thromb Vasc Biol. 2010. PMID: 20884874 Clinical Trial.

5

Influence of physiological changes in endogenous estrogen on circulating PCSK9 and LDL cholesterol.

Ghosh M, Gälman C, Rudling M, Angelin B. Ghosh M, et al. Among authors: galman c. J Lipid Res. 2015 Feb;56(2):463-9. doi: 10.1194/jlr.M055780. Epub 2014 Dec 22. J Lipid Res. 2015. PMID: 25535288 Free PMC article.

6

Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man.

Lundåsen T, Gälman C, Angelin B, Rudling M. Lundåsen T, et al. Among authors: galman c. J Intern Med. 2006 Dec;260(6):530-6. doi: 10.1111/j.1365-2796.2006.01731.x. J Intern Med. 2006. PMID: 17116003 Free article.

7

Pronounced variation in bile acid synthesis in humans is related to gender, hypertriglyceridaemia and circulating levels of fibroblast growth factor 19.

Gälman C, Angelin B, Rudling M. Gälman C, et al. J Intern Med. 2011 Dec;270(6):580-8. doi: 10.1111/j.1365-2796.2011.02466.x. Epub 2011 Nov 2. J Intern Med. 2011. PMID: 22003820 Free article.

8

Pharmacological interference with intestinal bile acid transport reduces plasma cholesterol in LDL receptor/apoE deficiency.

Gälman C, Ostlund-Lindqvist AM, Björquist A, Schreyer S, Svensson L, Angelin B, Rudling M. Gälman C, et al. FASEB J. 2003 Feb;17(2):265-7. doi: 10.1096/fj.02-0341fje. Epub 2002 Dec 3. FASEB J. 2003. PMID: 12475897

9

Monitoring hepatic cholesterol 7alpha-hydroxylase activity by assay of the stable bile acid intermediate 7alpha-hydroxy-4-cholesten-3-one in peripheral blood.

Gälman C, Arvidsson I, Angelin B, Rudling M. Gälman C, et al. J Lipid Res. 2003 Apr;44(4):859-66. doi: 10.1194/jlr.D200043-JLR200. Epub 2003 Jan 16. J Lipid Res. 2003. PMID: 12562858 Free article.

10

Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis.

Gälman C, Angelin B, Rudling M. Gälman C, et al. Gastroenterology. 2005 Nov;129(5):1445-53. doi: 10.1053/j.gastro.2005.09.009. Gastroenterology. 2005. PMID: 16285946

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters